Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K/AKT/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO)

Autor: Xin-He Zhou, Wen-Wen Zheng, Chao Zheng, Liang-Xue Wang, Ying Hong, Si-Si Dong, Chun-Ying Li
Rok vydání: 2018
Předmět:
0301 basic medicine
Endothelium
Nitric Oxide Synthase Type III
Phlorizin
Palmitic Acid
Medical Biochemistry
030204 cardiovascular system & hematology
Pharmacology
Nitric Oxide
Protective Agents
Transfection
Nitric oxide
03 medical and health sciences
chemistry.chemical_compound
Phosphatidylinositol 3-Kinases
0302 clinical medicine
Sodium-Glucose Transporter 1
Sodium-Glucose Transporter 2
Enos
medicine
Human Umbilical Vein Endothelial Cells
Humans
Lactase-Phlorizin Hydrolase
Endothelial dysfunction
Phosphorylation
RNA
Small Interfering

Protein kinase B
PI3K/AKT/mTOR pathway
biology
Chemistry
digestive
oral
and skin physiology

Reproducibility of Results
Endothelial Cells
General Medicine
medicine.disease
biology.organism_classification
030104 developmental biology
medicine.anatomical_structure
Phlorhizin
Diabetes Mellitus
Type 2

Endothelium
Vascular

Signal transduction
Proto-Oncogene Proteins c-akt
Signal Transduction
Zdroj: Medical Science Monitor Basic Research
ISSN: 2325-4416
Popis: BACKGROUND Sodium glucose transporter-2 inhibitors are the newest antidiabetic drugs that seem to be cardioprotective and can prevent type 2 diabetes in patients with high cardiovascular risks. Previous clinical trials have shown that these inhibitors can alleviate endothelial dysfunction, but the mechanism of action remains unknown. How SGLT inhibitor influences the release of NO in PA-induced HUVECs has never been reported. MATERIAL AND METHODS To explore the potential effects of the endothelial-protective mechanism of phlorizin and its impact on nitric oxide (NO), human umbilical vein endothelial cells (HUVECs) were incubated with palmitic acid (PA) and then treated with phlorizin. Western blotting was performed to assess the phosphorylation of AKT, eNOS, and IRS-1. To further explore potential targets, siRNA transfection was used to demonstrate the role of SGLT1 and SGLT2. RESULTS Phlorizin suppressed the expression of SGLT1 and SGLT2, activated the PI3K/AKT/eNOS signaling pathway, increased the output of NO, and promoted the consumption of glucose in PA-induced HUVECs. Through demonstrating siRNA suppression of the expression of SGLT1 and SGLT2 in PA-induced HUVECs, this study provides a new understanding of the mechanism behind SGLT1 and SGLT2. CONCLUSIONS Our data demonstrate that phlorizin ameliorates the endothelial dysfunction link with the activation of the PI3K/AKT/eNOS signaling pathway and augmentation of the release of NO, partially through suppressing the expression of SGLT1 and SGLT2 in PA-induced HUVECS.
Databáze: OpenAIRE